OA
BIO icon

OFI Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

OFI Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$361K Buy
2,685
+26
+1% +$3.74K 0.02% 897
2015
Q2 		$400K Sell
2,659
-223
-8% -$31.9K 0.02% 890
2015
Q1 		$390K Buy
2,882
+27
+0.9% +$3.35K 0.02% 897
2014
Q4 		$344K Sell
2,855
-265
-8% -$30.5K 0.02% 927
2014
Q3 		$354K Buy
3,120
+170
+6% +$20.1K 0.03% 832
2014
Q2 		$353K Buy
2,950
+464
+19% +$56.7K 0.03% 854
2014
Q1 		$319K Buy
2,486
+235
+10% +$30.1K 0.02% 853
2013
Q4 		$278K Buy
2,251
+189
+9% +$23K 0.02% 909
2013
Q3 		$242K Buy
2,062
+66
+3% +$7.78K 0.02% 857
2013
Q2 		$224K Buy
+1,996
New +$234K 0.02% 813

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return